# FDA Inspection 960815 - Biomat USA, Inc - January 13, 2016

Source: https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/b925fc57-3ee2-40eb-b52a-0873badc93c8
Source feed: FDA_Inspections

> FDA Inspection 960815 for Biomat USA, Inc on January 13, 2016. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 960815
- Company Name: Biomat USA, Inc
- Inspection Date: 2016-01-13
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1098274 - 2019-06-21](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/46ed5038-5551-4568-ad26-449011cef7ea)
- [FDA Inspection 867833 - 2014-02-27](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/2f375dc7-893f-421f-a146-3242a4d0ce10)
- [FDA Inspection 761209 - 2011-10-26](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/d0842821-2c16-4a91-9bff-2b2d406e23ae)
- [FDA Inspection 626356 - 2009-10-22](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/9ef2f9cf-dee7-4751-91be-ae6f64582572)

Company: https://www.keypedia.com/companies/biomat-usa-inc/109cb30a-c92b-414c-b7b8-9271fee234a1

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d